Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
757-799-1277 No services selected yet Cancel within 48 hours of appointment date/time to get a full refund.
Sources Sikiric P
MOTS-c targets AMPK-dependent insulin sensitization Regulatory status / FDA lists both peptides among bulk drug substances under evaluation for compounding Why No Direct Comparison Exists Neither AOD-9604 nor MOTS-c has advanced far enough in clinical development for a randomized head-to-head trial
How soon will I notice changes
1 To permit that, the FDA would need to add the peptides to whats known as the Section 503A Bulk Drug Substances List, or 503A Bulks List
US$ 24.28
US$ 22.47
US$ 20.14
US$ 20.32
US$ 20.91
